quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:04·266d
SECFiling
Third Harmonic Bio Inc. logo

SEC Form EFFECT filed by Third Harmonic Bio Inc.

THRD· Third Harmonic Bio Inc.
Health Care
Original source

Companies

  • THRD
    Third Harmonic Bio Inc.
    Health Care

Recent analyst ratings

  • Mar 28UpdateStifel$5.00
  • Feb 12UpdateMorgan Stanley$5.00
  • Feb 11UpdateRaymond James-
  • Aug 9UpdateMorgan Stanley$20.00
  • Jun 18UpdateStifel$23.00
  • Jun 7UpdateRaymond James$18.00

Related

  • INSIDER252d
    CEO Holles Natalie C. disposed of 1,218,836 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER252d
    Director Seidel Hans Martin disposed of 85,753 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER252d
    SEC Form 4 filed by Director Soloway Thomas P
  • INSIDER252d
    Director Iwicki Mark T disposed of 128,631 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER252d
    SEC Form 4 filed by Chief Financial & Bus. Officer Murphy Christopher M.
  • INSIDER252d
    SEC Form 4 filed by Director Gladstone Michael
  • INSIDER252d
    Director Bonita David P disposed of 5,779,071 shares, closing all direct ownership in the company (SEC Form 4)
  • SEC256d
    SEC Form 15-12G filed by Third Harmonic Bio Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022